J&J plans test of its COVID-19 vaccine candidate in 12-18 year olds soon
Reuters
Published Oct 30, 2020 12:36PM ET
NEW YORK (Reuters) - Johnson & Johnson plans to start testing its COVID-19 vaccine candidate in 12 to 18 year olds as soon as possible, a company executive said at a meeting held by the U.S. Centers for Disease Control and Prevention on Friday.
"We plan to go into children as soon as we possibly can, but very carefully in terms of safety," Dr. Jerry Sadoff of Johnson & Johnson told the panel. He said depending on safety and other factors, the company plans to test in younger children afterwards.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.